Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

50 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

NCT01844765

Conditions
Bone Marrow Diseases, Bronchial Diseases, Bronchiolitis, +23 more
Locations
  • Loma Linda University Cancer Center Loma Linda, California, United States
  • Lucile Salter Packard Children's Hospital at Stanford Palo Alto, California, United States
  • Nemours Childrens Hospital Orlando, Florida, United States
  • St. Mary's Hospital West Palm Beach, Florida, United States
View all 36 locations
View Trial Details
Completed

A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

NCT00471497

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +13 more
Locations
  • University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States
  • Kaiser Permanente - California Southern Dept of Kaiser South 3 San Diego, California, United States
  • Kaiser Permanente - California Northern Vallejo Med Center/Med Offices Vallejo, California, United States
  • Kaiser Permanente - California Northern Kaiser Med Vallejo, California, United States
View all 213 locations
View Trial Details
Completed

Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis

NCT01369498

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Stanford University Medical center Stanford, California, United States
  • Washington University in St. Louis St Louis, Missouri, United States
  • Oncology Hematology Care Clinical Trials Cincinnati, Ohio, United States
View Trial Details
Completed

A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF

NCT01787552

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 18 locations
View Trial Details
Completed

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

NCT01201811

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +4 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • Chiayi Chang Gung Memorial Hospital Chiayi City, Taiwan
  • Buddhist Tzu Chi General Hospital-Hualien Tzu Chi Medical Center Hualien City, Taiwan
  • Kaohsiung Medical Hospital University Kaohsiung City, Taiwan
View Trial Details
Completed

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

NCT01511289

Conditions
Bone Marrow Diseases, Chromosome Aberrations, Chronic Disease, +14 more
Locations
  • Local Institution Jakarta, Indonesia
  • Local Institution Batangas, Philippines
  • Local Institution Manila, Philippines
  • Local Institution Busan, South Korea
View all 22 locations
View Trial Details

Related conditions